DSM Firmenich AG (DSMFF)
109.28
0.00 (0.00%)
USD |
OTCM |
Dec 13, 16:00
Price Chart
Key Stats
Price and Performance | |
---|---|
Market Cap | 28.99B |
52 Week High (Daily) | Upgrade |
52 Week Low (Daily) | Upgrade |
All-Time High (Daily) | Upgrade |
Year to Date Total Returns (Daily) | Upgrade |
1 Month Total Returns (Daily) | Upgrade |
1 Year Total Returns (Daily) | 4.47% |
Valuation | |
PE Ratio | -- |
PE Ratio (Forward) | Upgrade |
PS Ratio | 2.163 |
Price to Book Value | 1.223 |
EV to EBITDA | Upgrade |
Dividend | |
---|---|
Dividend | 2.687 |
Dividend Yield (Forward) | Upgrade |
Financials | |
Revenue (5 Year Growth) | Upgrade |
Revenue (Quarterly YoY Growth) | Upgrade |
EPS Diluted (5 Year Growth) | Upgrade |
EPS Diluted (Quarterly YoY Growth) | Upgrade |
Debt to Equity Ratio | 0.2071 |
Return on Equity | Upgrade |
Return on Assets | Upgrade |
Risk | |
Beta (5Y) | Upgrade |
Max Drawdown (5Y) | -- |
Profile
DSM-Firmenich is a global science-based company formed in 2023 through the merger of DSM, a Dutch nutrition, health, and sustainable living player, and Switzerland-based Firmenich, the third-largest player in the flavor and fragrance market. The company serves a wide range of end-consumer markets providing nutrition solutions ranging from animal feed to medical and early-life nutrition, fragrances for personal-, home-, and laundry-care brands, prestige perfumes, and other ingredients for food and beverage, home, and personal care. DSM-Firmenich has nearly 30,000 employees, with more than 2,000 scientists and engineers spread across 15 research and development facilities. |
URL | https://www.dsm-firmenich.com/corporate/home.html |
Investor Relations URL | N/A |
HQ State/Province | N/A |
Sector | Materials |
Industry | Chemicals |
Equity Style | Large Cap/Growth |
Next Earnings Release | Feb. 14, 2025 (est.) |
Last Earnings Release | Oct. 31, 2024 |
Next Ex-Dividend Date | N/A |
Last Ex-Dividend Date | May. 09, 2024 |
Ratings
Profile
DSM-Firmenich is a global science-based company formed in 2023 through the merger of DSM, a Dutch nutrition, health, and sustainable living player, and Switzerland-based Firmenich, the third-largest player in the flavor and fragrance market. The company serves a wide range of end-consumer markets providing nutrition solutions ranging from animal feed to medical and early-life nutrition, fragrances for personal-, home-, and laundry-care brands, prestige perfumes, and other ingredients for food and beverage, home, and personal care. DSM-Firmenich has nearly 30,000 employees, with more than 2,000 scientists and engineers spread across 15 research and development facilities. |
URL | https://www.dsm-firmenich.com/corporate/home.html |
Investor Relations URL | N/A |
HQ State/Province | N/A |
Sector | Materials |
Industry | Chemicals |
Equity Style | Large Cap/Growth |
Next Earnings Release | Feb. 14, 2025 (est.) |
Last Earnings Release | Oct. 31, 2024 |
Next Ex-Dividend Date | N/A |
Last Ex-Dividend Date | May. 09, 2024 |